SAN
80.24
-1.64%↓
UCB
237.4
-3.73%↓
SHL.DE
35.42
-1.69%↓
ARGX
666.6
-2.49%↓
VIE
35.59
+0.08%↑
SAN
80.24
-1.64%↓
UCB
237.4
-3.73%↓
SHL.DE
35.42
-1.69%↓
ARGX
666.6
-2.49%↓
VIE
35.59
+0.08%↑
SAN
80.24
-1.64%↓
UCB
237.4
-3.73%↓
SHL.DE
35.42
-1.69%↓
ARGX
666.6
-2.49%↓
VIE
35.59
+0.08%↑
SAN
80.24
-1.64%↓
UCB
237.4
-3.73%↓
SHL.DE
35.42
-1.69%↓
ARGX
666.6
-2.49%↓
VIE
35.59
+0.08%↑
SAN
80.24
-1.64%↓
UCB
237.4
-3.73%↓
SHL.DE
35.42
-1.69%↓
ARGX
666.6
-2.49%↓
VIE
35.59
+0.08%↑
24h
Corrente
Minimo
111.55
Massimo
112.05
Entrata | 250M 902M |
|---|---|
Vendite | 63M 5.3B |
Rendimento da dividendi | 1.34 |
Margine di Profitto | 16.961 |
Raccomandazioni | Acquista |
|---|---|
Previsioni per 12 mesi | +23.16% upside |
Rendimento da dividendi Media del settore | 1.34% 2.24% |
|---|---|
Utili prossimi | 13 mag 2026 |
Capitalizzazione di Mercato | 98B |
|---|---|
Apertura precedente | 111.65 |
Chiusura precedente | 111.65 |
By Trading Central
Fiducia
Strong Bearish Evidence
121.15 / 123.55 Supporto e resistenza
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
5 mar 2026, 06:28 UTC
Germany's Merck KGaA Expects Currency Headwinds to Weigh on Earnings
DJ
LeggI
13 nov 2025, 13:40 UTC
Germany's Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results -- Update
DJ
LeggI
13 nov 2025, 06:24 UTC
Germany's Merck KGaA Posts Higher Earnings on Organic Growth Across Units
DJ
LeggI
1 apr 2026, 12:06 UTC
Merck KGaA Completes Acquisition of JSR Life Sciences' Chromatography Business
DJ
LeggI
5 mar 2026, 08:40 UTC
Germany's Merck KGaA Issues Weaker-Than-Expected Guidance -- Market Talk
DJ
LeggI
5 mar 2026, 06:00 UTC
Merck KGaA Sees 2026 Ebitda Before Special Items at EUR5.5B-EUR6B
DJ
LeggI
5 mar 2026, 06:00 UTC
Merck KGaA Sees 2026 Adj EPS EUR7.10-Adj EPS EUR8
DJ
LeggI
5 mar 2026, 06:00 UTC
Analysts Saw Merck KGaA 2025 Ebitda Before Special Items EUR6.1B
DJ
LeggI
5 mar 2026, 06:00 UTC
Merck KGaA Sees 2026 Sales EUR20B-EUR21B
DJ
LeggI
5 mar 2026, 06:00 UTC
Merck KGaA Sees 2026 Organic Net Sales Ranging From 1% Fall to 2% Rise
DJ
LeggI
5 mar 2026, 06:00 UTC
Merck KGaA 2025 Adj EPS EUR8.34
DJ
LeggI
5 mar 2026, 06:00 UTC
Analysts Saw Merck KGaA 2025 Net Sales at EUR21.14B
DJ
LeggI
5 mar 2026, 06:00 UTC
Merck KGaA Expects Considerable Foreign-Exchange Headwinds in 2026
DJ
LeggI
5 mar 2026, 06:00 UTC
Merck KGaA Keeps Dividend at EUR2.20 a Share
DJ
LeggI
5 mar 2026, 06:00 UTC
Merck KGaA 2025 After-Tax Profit EUR2.615B
DJ
LeggI
5 mar 2026, 06:00 UTC
Germany's Merck KGaA Says Organic Net Sales Grew 3.1% in 2025
DJ
LeggI
5 mar 2026, 06:00 UTC
Merck KGaA 2025 Sales EUR21.1B
DJ
LeggI
5 mar 2026, 06:00 UTC
Merck KGaA 2025 Ebitda Before Special Items EUR6.11B
DJ
LeggI
12 feb 2026, 15:20 UTC
Sanofi Shares Fall After CEO Change -- Update
DJ
LeggI
20 gen 2026, 09:54 UTC
DAVOS: Merck KGaA Not in a Hurry for M&A, CEO Says -- Market Talk
DJ
LeggI
13 nov 2025, 07:57 UTC
Germany's Merck KGaA Beats Expectations With Strong Results -- Market Talk
DJ
LeggI
13 nov 2025, 06:00 UTC
Merck KGaA Sees 2025 Ebitda Before Exceptional Items at EUR6B-EUR6.2B
DJ
LeggI
13 nov 2025, 06:00 UTC
Merck KGaA Narrows 2025 View To Sales EUR20.8B-EUR21.4B
DJ
LeggI
13 nov 2025, 06:00 UTC
Merck KGaA Sees 2025 Organic Ebitda Before Exceptional Items Growth of 5%-7%
DJ
LeggI
13 nov 2025, 06:00 UTC
Merck KGaA Had Guided for 2025 Organic Sales Growth of 2% to 5%
DJ
LeggI
13 nov 2025, 06:00 UTC
Merck KGaA Says Guidance Midpoint Remains Unchanged
DJ
LeggI
13 nov 2025, 06:00 UTC
Merck KGaA Had Guided for 2025 Organic Ebitda Before Exceptional Items Growth of 4%-8%
DJ
LeggI
13 nov 2025, 06:00 UTC
Merck KGaA Sees 2025 Organic Sales Growth of Around 3%
DJ
LeggI
13 nov 2025, 06:00 UTC
Merck KGaA 3Q After-Tax Profit EUR898M
DJ
LeggI
13 nov 2025, 06:00 UTC
Merck KGaA: 3Q Net Sales Rose 5.2% Organically With Solid Growth Across Sectors
DJ
LeggI
Modifica del prezzo
By TipRanks
Previsioni per 12 mesi
Media 138 EUR 23.16%
Alto 152 EUR
Basso 112 EUR
Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Merck KGaA - Dist negli ultimi 3 mesi.
By TipRanks
Acquista
8 ratings
5
Acquista
3
Mantieni
0
Vendi
Basato sugli analisti di 8 che hanno fornito valutazioni azionarie a Merck KGaA - Dist negli ultimi 3 mesi.
By Trading Central
A breve termine
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
A termine intermedio
Neutral Evidence
The bullish and bearish events are balanced.
A lungo termine
Bearish Evidence
All events are bearish.
Spese di vendita e di amministrazione
Spese operative
Utile prima delle imposte
Vendite
Costo delle vendite
Utile lordo sulle vendite
Interessi passivi sul debito
EBITDA
Utile operativo
$